QURE uniQure NV

uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, announced today that its management will present at the 36th Cowen & Company Healthcare Conference to be held on March 7 – 9, 2016 at the Boston Marriott Copley Place, Boston, Massachusetts.

Date: March 9, 2016

Time: 11:20 a.m. EST / 5:20 p.m. CET

Speaking for uniQure: Daniel Soland (Chief Executive Officer)

The live webcast, including a slide presentation, can be accessed through the following link: http://wsw.com/webcast/cowen30/qure or by accessing the link displayed in the "Events" section on the "Media" page of the uniQure website at: http://www.uniqure.com/news/calendar-of-events/. The replay of the webcast will be available after the conclusion of the live event and archived on the uniQure website for at least 30 days following the webcast.

About uniQure

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com

CONTACT: uniQure:
         Eva Mulder
         Direct : +31 20 240 6103
         Main: +31 20 240 6000
         e.mulder@uniQure.com
         
         Media inquiries:
         Gretchen Schweitzer
         MacDougall Biomedical Communications
         Direct: +49 172 861 8540
         Main: +49 89 2424 3494 or +1 781 235 3060
         gschweitzer@macbiocom.com